v3.23.3
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:              
Net loss $ (4,667,856) $ (7,162,596) $ (6,722,154) $ (6,019,251) $ (17,472,808) $ (6,173,268)  
Adjustments to reconcile net income (loss) to net cash used in operating activities              
Depreciation and amortization         3,487,866 43,718  
Noncash lease expense         70,545 71,288  
Stock compensation         917,057 988,498  
Stock option expense         1,611,795 9,956,219  
Accrued investment income         (130,990) (259,867)  
Impairment loss on digital assets         822,650 404,341  
Impairment loss on hosting deposits         36,691    
Impairment loss on Symbiont assets 750,678       750,678    
Unrealized loss (gain) on marketable securities (2,058)   13,000   (6,436) 36,900  
Unrealized loss (gain) on investment and equity securities         10,317,613 (11,034,828)  
Realized loss (gain) on securities         (1,788) 349,920  
Realized gain on convertible note securities           (287,778)  
Realized gain on sale of digital assets         (1,333,899)    
Proceeds from securities         554,036 2,565,893  
Convertible debt and interest converted into marketable securities           844,882  
Investment in marketable Securities         (739,616) (844,882)  
Credit loss on Seastar Medical Holding Corporation notes recievable 22,344       22,344    
Reversal of allowance loss on debt security         (1,052,543)    
Change in operating assets and liabilities              
Prepaid expenses and other assets         (123,221) 807,352  
Hosting deposits         (54,691)    
Repayments to related party         (31,090) (45,605)  
Accounts payable and accrued expenses         682,405 172,723  
Mining of digital assets         (8,352,805) (42,157)  
Proceeds from sale of digital assets         7,487,058    
Lease liability payments         (70,563) (75,574)  
Deferred taxes and taxes payable           841,678  
Net cash used in operating activities         (2,609,712) (1,680,547)  
CASH FLOWS FROM INVESTING ACTIVITIES:              
Capital expenditures         (1,913,303) (15,380)  
Investment in note receivable         (100,000) (350,000)  
Investment in note receivable - related party           (2,785,000)  
Collection of note receivable         1,761,727    
Investment in digital assets         (35,157) (978,441)  
Proceeds from sale of purchased digital assets         43,678    
Symbiont asset acquisition         (402,359)    
Deposits for mining equipment           (16,467,402)  
Net cash used in investing activities         (640,170) (20,588,739)  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Insurance financing repayments         (499,453) (114,688)  
Insurance financing         86,886    
Issue costs from the issuance of common stock         (106,550)    
Net cash used in financing activities         (519,117) (114,688)  
NET DECREASE IN CASH         (3,768,999) (22,383,974)  
CASH - BEGINNING OF PERIOD   $ 4,238,006   $ 32,559,185 4,238,006 32,559,185 $ 32,559,185
CASH - END OF PERIOD $ 469,007   $ 10,175,211   469,007 10,175,211 $ 4,238,006
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES              
ROU assets and operating lease obligation recognized         21,887 300,787  
Reclassification of mining equipment deposit to fixed assets, net         1,177,226 21,986,382  
SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION              
Cash paid for taxes           470,000  
Original Product [Member]              
CASH FLOWS FROM INVESTING ACTIVITIES:              
Net collections of finance receivables         (8,765) 19,049  
Special Product [Member]              
CASH FLOWS FROM INVESTING ACTIVITIES:              
Net collections of finance receivables         $ 14,009 $ (11,565)  

Source

HTML PDF
ZIP